ANTICOAGULANT MONITORING
ANTI-Xa
LYOPHILIZED PLASMAS

TECHNOVIEW RIVAROXABAN CONT MEDIUM

Cat Num. Conditioning  
4-50901735 x 1,0 mL
Set of medium control plasmas to be used for the quality control of rivaroxaban measurements.
Control Medium Plasmas are prepared from citrated plasmas supplemented with around 110 ng/mL of rivaroxaban.
Characteristics
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer. In a number of countries it is marketed as Xarelto®.

THEY TRUST US

OUR PARTNERS